Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma

European Journal of Cancer

Volumn 47, Issue 4, 2011, Pages 572-578

  De Ioris, Maria Antonietta ^a   Castellano, Aurora ^a   Ilari, Ilaria ^a   Garganese, Maria Carmen ^a   Natali, Gianluigi ^a   Inserra, Alessandro ^a   Vito, Rita De ^a   Rav, Lucilla ^a   Pasquale, Maria Debora De ^a   Locatelli, Franco ^a,b   Donfrancesco, Alberto ^a   Jenkner, Alessandro ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Children; Induction; Metastasis; Neuroblastoma; Remission; Topotecan

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ANTIBIOTIC AGENT; BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; ISOTRETINOIN; MELPHALAN; MESNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA; TOPOTECAN; VINCRISTINE;

ARTICLE; BLOODSTREAM INFECTION; CANCER LOCALIZATION; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; FEMALE; HEMORRHAGIC CYSTITIS; HUMAN; INFANT; INFECTION; MALE; METASTASIS; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEUROBLASTOMA; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SINGLE DRUG DOSE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR VOLUME;

ABDOMINAL NEOPLASMS; ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; ETOPOSIDE; FEMALE; HUMANS; IFOSFAMIDE; INFANT; KAPLAN-MEIER ESTIMATE; LOMUSTINE; MALE; MELPHALAN; MESNA; NEUROBLASTOMA; PILOT PROJECTS; RISK FACTORS; THORACIC NEOPLASMS; TOPOTECAN; TREATMENT OUTCOME;

EID: 79851510815     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.10.023     Document Type: Article

References (30)

1. J.L. Weinstein, H.M. Katzenstein, and S.L. Cohn Advances in the diagnosis and treatment of neuroblastoma Oncologist 8 2003 278 292 (Pubitemid 36648814)
2. K.K. Matthay, J.G. Villablanca, and R.C. Seeger Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group N Engl J Med 341 1999 1165 1173 (Pubitemid 29480654)
3. K.K. Matthay, C.P. Reynolds, and R.C. Seeger Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study J Clin Oncol 27 2009 1007 1013
4. B. De Bernardi, B. Nicolas, and L. Boni Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma J Clin Oncol 21 2003 1592 1601 (Pubitemid 46594114)
5. A.D. Pearson, C.R. Pinkerton, and I.J. Lewis High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial Lancet Oncol 9 2008 247 256 (Pubitemid 351722944)
6. N.V. Cheung, and G. Heller Chemotherapy dose intensity correlates strongly with response, median survival and median progression-free survival in metastatic neuroblastoma J Clin Oncol 9 1991 1050 1058
7. B.H. Kushner, K. Kramer, and M.P. LaQuaglia Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma J Clin Oncol 22 2004 4888 4892 (Pubitemid 46638612)
8. R. Ladenstein, T. Philip, and C. Lasset Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry J Clin Oncol 16 1998 953 965 (Pubitemid 28108728)
9. D. Frappaz, J. Michon, and C. Coze LMCE3 treatment strategy: results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis J Clin Oncol 18 2000 468 476 (Pubitemid 30078528)
10. W.C. Zamboni, C.F. Stewart, and J. Thompson Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts J Natl Cancer Inst 90 1998 505 511 (Pubitemid 28182543)
11. S.M. Blaney, M.N. Needle, and A. Gillespie Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study Clin Cancer Res 4 1998 357 360 (Pubitemid 28122750)
12. R.L. Saylors 3rd, K.C. Stine, and J. Sullivan Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study J Clin Oncol 19 2001 3463 3469 (Pubitemid 32730082)
13. B.H. Kushner, K. Kramer, and P.A. Meyers Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors Med Pediatr Oncol 35 2000 468 474
14. J.R. Park, C.F. Stewart, and W.B. London A topotecan-containing induction regimen for treatment of high risk neuroblastoma J Clin Oncol 24 18S 2006 9013 [ASCO Annual Meeting Proceedings Part I]
15. A. Donfrancesco, A. Jenkner, and A. Castellano Ifosfamide/carboplatin/ etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age Acta Paediatr Suppl 93 2004 6 11 (Pubitemid 38570249)
16. M.S. Cairo, V. Shen, and M.D. Krailo Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report J Pediatr Hematol Oncol 23 1 2001 30 38 (Pubitemid 32124982)
17. I.M. Ambros, J. Benard, and M. Boavida Quality assessment of genetic markers used for therapy stratification J Clin Oncol 21 2003 2077 2084 (Pubitemid 46606355)
18. G.M. Brodeur, J. Pritchard, and F. Berthold Revisions in the international criteria for neuroblastoma diagnosis, staging and response to treatment J Clin Oncol 11 1993 1466 1477 (Pubitemid 23228250)
19. B.H. Kushner, S. Wolden, and M.P. LaQuaglia Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery J Clin Oncol 19 2001 2821 2828 (Pubitemid 32538190)
20. International Common Toxicity Criteria Version 3 (CTC.3). Available from URL: http://www.fda.gov/cder/cancer/toxicityframe.htm.
21. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observation J Am Stat Assoc 53 1959 457 481
22. N.K. Cheung, B.H. Kushner, and M. LaQuaglia N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age Med Pediatr Oncol 36 2001 227 230
23. D. Valteau-Couanet, J. Michon, and A. Boneu Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol J Clin Oncol 23 2005 532 540 (Pubitemid 46224230)
24. B.H. Kushner, K. Kramer, and S. Modak Camptothecin analogs (irinotecan or topotecan) plus high-dose cyclophosphamide as preparative regimens for antibody-based immunotherapy in resistant neuroblastoma Clin Cancer Res 10 2004 84 87 (Pubitemid 38114165)
25. A. Garaventa, R. Luksch, and S. Biasotti A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastoma Cancer 98 2003 2488 2494 (Pubitemid 37466665)
26. V.M. Santana, W.L. Furman, and C.A. Billups Improved response in high-risk neuroblastoma with protracted topotecan administration using a pharmacokinetically guided dosing approach J Clin Oncol 20 23 2005 4039 4047 (Pubitemid 46211308)
27. C.S. Kretschmar, M. Kletzel, and K. Murray Response to paclitaxel, topotecan, and topotecan-cyclophosphamide in children with untreated disseminated neuroblastoma treated in an upfront phase II investigational window: A Pediatric Oncology Group Study J Clin Oncol 22 2004 4119 4126 (Pubitemid 41185181)
28. T. Simon, A. Längler, and U. Harnischmacher Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial J Cancer Res Clin Oncol 133 2007 653 661 (Pubitemid 47077057)
29. W.B. London, C.N. Frantz, and L.A. Campbell Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study J Clin Oncol 28 2010 3808 3815
30. J.C. Panetta, P. Schaiquevich, and V.M. Santana Using pharmacokinetic and pharmacodynamic modeling and simulation to evaluate importance of schedule in topotecan therapy for pediatric neuroblastoma Clin Cancer Res 14 2008 318 325 (Pubitemid 351378008)